Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2026-01-05 @ 1:21 AM
Study NCT ID:
NCT03095651
Status:
COMPLETED
Last Update Posted:
2019-04-01
First Post:
2017-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-27
First Submit QC Date:
None
Study First Post Date:
2017-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2018-12-14
Results First Submit QC Date:
None
Results First Post Date:
2019-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-29
Last Update Post Date:
2019-04-01
Last Update Post Date Type:
ACTUAL